Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 67,783 | 67,336 | 60,370 | 55,105 | 36,703 |
| Cost of Goods | 23,713 | 22,882 | 21,643 | 17,472 | 12,403 |
| Gross Profit | 44,070 | 44,454 | 38,727 | 37,633 | 24,300 |
| Operating Expenses | 60,031 | 57,669 | 56,051 | 45,579 | 70,118 |
| Operating Income | -15,248 | -12,333 | -16,681 | -7,474 | -45,415 |
| Other Income | 784 | 1,016 | 1,202 | -1,716 | -248 |
| Pre-tax Income | -14,464 | -11,317 | -15,479 | -9,190 | -45,663 |
| Income Tax | -3 | -789 | -1,350 | -152 | -3,795 |
| Net Income Continuous | -14,461 | -10,528 | -14,129 | -9,038 | -41,868 |
| Net Income | $-14,461 | $-10,528 | $-14,129 | $-9,038 | $-41,868 |
| EPS Basic Total Ops | -0.20 | -0.12 | -0.20 | -0.13 | -0.66 |
| EPS Basic Continuous Ops | -0.20 | -0.12 | -0.20 | -0.13 | -0.66 |
| EPS Diluted Total Ops | -0.20 | -0.12 | -0.20 | -0.13 | -0.66 |
| EPS Diluted Continuous Ops | -0.20 | -0.12 | -0.20 | -0.13 | -0.66 |
| EBITDA(a) | $-8,692 | $-5,929 | $-10,542 | $-2,974 | $-42,865 |